Logo image of EVMT.CA

EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) Stock Fundamental Analysis

TSX-V:EVMT - TSX Venture Exchange - CA30053H1055 - Common Stock - Currency: CAD

0.005  0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to EVMT. EVMT was compared to 16 industry peers in the Health Care Equipment & Supplies industry. EVMT may be in some trouble as it scores bad on both profitability and health. EVMT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year EVMT has reported negative net income.
In the past year EVMT had a positive cash flow from operations.
EVMT had negative earnings in each of the past 5 years.
In the past 5 years EVMT reported 4 times negative operating cash flow.
EVMT.CA Yearly Net Income VS EBIT VS OCF VS FCFEVMT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M -15M -20M

1.2 Ratios

EVMT has a Return On Assets of -66.99%. This is in the better half of the industry: EVMT outperforms 68.75% of its industry peers.
Industry RankSector Rank
ROA -66.99%
ROE N/A
ROIC N/A
ROA(3y)-20.97%
ROA(5y)-17.84%
ROE(3y)-154.4%
ROE(5y)-98.04%
ROIC(3y)N/A
ROIC(5y)N/A
EVMT.CA Yearly ROA, ROE, ROICEVMT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 -100 -200 -300

1.3 Margins

EVMT's Gross Margin of 33.80% is on the low side compared to the rest of the industry. EVMT is outperformed by 62.50% of its industry peers.
In the last couple of years the Gross Margin of EVMT has declined.
EVMT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-27.65%
GM growth 5YN/A
EVMT.CA Yearly Profit, Operating, Gross MarginsEVMT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K

More info and screens

2

2. Health

2.1 Basic Checks

EVMT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EVMT has more shares outstanding
The number of shares outstanding for EVMT has been increased compared to 5 years ago.
EVMT has a worse debt/assets ratio than last year.
EVMT.CA Yearly Shares OutstandingEVMT.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
EVMT.CA Yearly Total Debt VS Total AssetsEVMT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

EVMT has an Altman-Z score of -2.59. This is a bad value and indicates that EVMT is not financially healthy and even has some risk of bankruptcy.
EVMT has a Altman-Z score of -2.59. This is in the better half of the industry: EVMT outperforms 68.75% of its industry peers.
EVMT has a debt to FCF ratio of 3.25. This is a good value and a sign of high solvency as EVMT would need 3.25 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.25, EVMT belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.25
Altman-Z -2.59
ROIC/WACCN/A
WACC8.49%
EVMT.CA Yearly LT Debt VS Equity VS FCFEVMT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M

2.3 Liquidity

A Current Ratio of 0.51 indicates that EVMT may have some problems paying its short term obligations.
EVMT has a worse Current ratio (0.51) than 62.50% of its industry peers.
A Quick Ratio of 0.24 indicates that EVMT may have some problems paying its short term obligations.
EVMT's Quick ratio of 0.24 is on the low side compared to the rest of the industry. EVMT is outperformed by 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.24
EVMT.CA Yearly Current Assets VS Current LiabilitesEVMT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.50% over the past year.
EVMT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -39.95%.
The Revenue has been growing by 73.88% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)4.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-140%
Revenue 1Y (TTM)-39.95%
Revenue growth 3Y438.98%
Revenue growth 5Y73.88%
Sales Q2Q%-49.05%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-400%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.65%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EVMT.CA Yearly Revenue VS EstimatesEVMT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
EVMT.CA Yearly EPS VS EstimatesEVMT.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 -0.01 -0.02 -0.03 -0.04 -0.05

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

EVMT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year EVMT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EVMT.CA Price Earnings VS Forward Price EarningsEVMT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of EVMT indicates a rather cheap valuation: EVMT is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 0.06
EV/EBITDA N/A
EVMT.CA Per share dataEVMT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

EVMT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EVOME MEDICAL TECHNOLOGIES I

TSX-V:EVMT (5/6/2025, 7:00:00 PM)

0.005

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-25 2025-03-25/amc
Earnings (Next)05-07 2025-05-07
Inst Owners9.89%
Inst Owner ChangeN/A
Ins Owners0.19%
Ins Owner ChangeN/A
Market Cap300.85K
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF 0.06
P/OCF 0.06
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)0.09
FCFY1784.34%
OCF(TTM)0.09
OCFY1796.34%
SpS0.8
BVpS-0.06
TBVpS-0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -66.99%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.8%
FCFM 11.1%
ROA(3y)-20.97%
ROA(5y)-17.84%
ROE(3y)-154.4%
ROE(5y)-98.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-27.65%
GM growth 5YN/A
F-Score3
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.25
Debt/EBITDA N/A
Cap/Depr 1.09%
Cap/Sales 0.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.24
Altman-Z -2.59
F-Score3
WACC8.49%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.22%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-140%
EPS Next Y-400%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-39.95%
Revenue growth 3Y438.98%
Revenue growth 5Y73.88%
Sales Q2Q%-49.05%
Revenue Next Year-0.65%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year137.83%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y371.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y434.86%
OCF growth 3YN/A
OCF growth 5YN/A